NCT03618550 2026-04-16Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting257 enrolled
NCT06059391 2026-03-10CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantCity of Hope Medical CenterPhase 2 Recruiting216 enrolled